glp 1 receptor agonists names GLP-1 RA Medications Discontinuation in Diabetes Care A schematic overview of GLP-1
Description
doi: 10.1152/ajpendo.00347.2016
What is excluded from the scope of this report

We are not prescribing it
Alternating between semaglutide and tirzepatide is an approach some patients and providers explore, though insurance coverage for such protocols can be challenging to navigate
Strelitz J, Lawlor ER, Wu Y, Estlin A, Nandakumar G, Ahern AL, et al

M., & Yeh, M
